‘Poor’ Humira performance triggers Q3 sales miss for AbbVie, but SG&A beat keeps EPS in line

'Poor' Humira performance triggers Q3 sales miss for AbbVie, but SG&A beat keeps EPS in line chelfand Fri, 10/28/2016 - 11:54…
Read the full story: Feed